AI assistant
Sending…
Novonesis AS — M&A Activity 2022
Dec 12, 2022
3377_iss_2022-12-12_50eede4e-45c2-450a-a059-e58a5204fee6.html
M&A Activity
Open in viewerOpens in your device viewer
Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
Attachment

More from Novonesis AS
Director's Dealing
2026
May 6
Director's Dealing
2026
May 6
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27